SCHEMBL8351183

SCHEMBL8351183

Cc1ccc(C2(C(=O)CN3CCCCC3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ OPRM1 P35372 1/20 0.45
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ POLB P06746 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ ADRA2B P18089 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ LMNA P02545 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HSD11B1 P28845 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351187 0.98 USP2 (0.46) HPGDNPC1RAB9ASMN1; SMN2USP2
SCHEMBL8353497 0.94 USP2 (0.45) HPGDNPC1RAB9ASMN1; SMN2USP2
SCHEMBL8351554 0.94 USP2 (0.45) HPGDNPC1RAB9ASMN1; SMN2USP2
SCHEMBL14347908 0.85 MEN1 (0.50) NPC1RAB9ASMN1; SMN2OPRM1MEN1
SCHEMBL5643072 0.83 OPRM1 (0.44) OPRM1MEN1KMT2ASIGMAR1HRH3
SCHEMBL14347919 0.83 MEN1 (0.48) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL14347918 0.83 MEN1 (0.48) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL16523027 0.81 HSD11B1 (0.62) NPC1SMN1; SMN2OPRM1SIGMAR1LMNA
SCHEMBL16507031 0.80 KMT2A (0.56) NPC1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL19242638 0.80 KMT2A (0.60) NPC1SMN1; SMN2MEN1KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 — — WO disclosed
Send feedback